Public Release: 

The Trojan horse of Staphylococcus aureus

The infectious bacterium diverts to its advantage a structure set up by human cells, in order to destroy them and invade the organism

Université de Genève

IMAGE

IMAGE: Epithelial cells with nuclei marked in blue. ADAM10, which binds to the α-toxin of Staphylococcus aureus, is located in the adherens junctions that encircle the cells (yellow). view more 

Credit: © Sandra Citi, UNIGE

Staphylococcus aureus causes different types of infections in humans, some of which are lethal. One of its most powerful weapons is α-toxin, which destroys host cells by forming pores in their membranes. Researchers at the University of Geneva (UNIGE), Switzerland, have identified the mechanism that allows these pores to be particularly harmful, by being anchored to contacts sites between cells. The study, published in the journal Cell Reports, uncovers how different proteins of human cells assemble into a complex to which pores are docked, and then molecularly "locked" to stabilize them. The biologists also demonstrate that blocking the assembly of the complex by removing one or the other of its elements allows pores to be removed from the membrane and cells to survive. Identifying the host's cellular mechanisms that contribute to the virulence of toxins is essential to develop therapeutic approaches against antibiotic-resistant bacteria.

The epithelial cells that line the mucous membranes and the skin are the first and principal barriers that Staphylococcus aureus must cross in order to invade the organism. The attack arsenal of this pathogen includes a very effective weapon, α-toxin, which assembles into pores that pierce the membranes of the host cells. When membranes become permeable, the DNA breaks down and the cells eventually enter a process of self-destruction.

Adherent junctions contribute to bacterial virulence

The membranes of our epithelial cells are equipped with adherens junctions, which contribute to maintaining the integrity of our tissues. These junctions are composed of various proteins that allow adjacent cells to adhere to each other and that are internally connected to - and stabilized by - the cytoskeleton. "Three years ago, we discovered that several components of the adherens junctions play a role in the virulence of α-toxin, but we did not understand the underlying mechanisms at work", explains Sandra Citi, Professor at the Department of Cell Biology of the UNIGE Faculty of Science.

What happens when Staphylococcus aureus secretes α-toxin in large quantities near the epithelial cells? In collaboration with researchers from Stanford University and Inserm, the biologists from UNIGE have put together the pieces of the puzzle and uncovered the mechanism. "We already knew that the toxin binds to a cell membrane protein called ADAM10, which causes pores to form and cluster in the same location", says Jimit Shah, a researcher from the Geneva group and first author of the study.

A molecular Lego docks and locks the pores of the toxin

The scientists have discovered the existence of a complex formed by four different proteins of the host, whose assembly allows ADAM10 to dock to the adherens junctions and to be stabilized by a molecular lock. The bacteria thus divert a mechanism present in the membranes of epithelial cells and use it to destroy them and colonize the underlying tissues.

Is there a way to counter the effect of the bacterial weapon? "We have demonstrated that each of the four components of the complex is crucial for the whole mechanism to function. Inhibiting the proper formation of the complex indeed hinders the proper assembly of toxin pores at the adherens junctions", Jimit Shah adds. The pores formed by the α-toxin outside the junction are easily removed from the cell surface by the cell, resulting in the recovery of the damaged cell and ensuring its survival.

Many strains of Staphylococcus aureus have become resistant to antibiotics, and some are even impervious to all existing treatments. "A new potential therapeutic approach could be targeting the complex we discovered. The development of a clinical molecule capable of inhibiting interactions within the complex would likely be an obstacle to the spreading of multidrug-resistant strains", concludes Sandra Citi.

###

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.